Paula Albuquerque

Assets Strategic Planning UCB

Paula has 20 years of experience with a comprehensive US and ex-US global background within the healthcare, pharmaceutical, biotech, and management consulting sectors. She is known as an innovative, strategic and motivational leader with a passion for driving enhanced and sustainable access to healthcare and medicines for all individuals. Paula’s work helps illuminate future opportunities as well as challenges for how innovation can be brought to market in an affordable way because of the value the health solution creates to the specific ecosystem - patients, caregivers, health systems, markets, companies, and society – is fully considered. Therefore, her work paves the way for responsive adoption when innovation is launched and for universal sustainable funding, so that all patients who stand to benefit from the new health solutions are included. Paula’s areas of expertise span across industry value chain including Strategic Planning, Launch and Operational Excellence, Market Access, Price and Negotiations. She has a proven track record in leading Global, Regional and Local product launches, initially as a consultant and after working in the Pharmaceutical Industry in different roles, teams and therapeutic areas. Paula brings a unique approach to her leadership and work combining a Doctorate in Pharmacy and business acumen gained through education (INSEAD Chief Strategy Officer Programme, Executive MBA at IESE and MSc in Health Economics at University Pompeu Fabra), practical experience in international, multi-lingual and cross-cultural pharmaceutical/biotech/consulting industries (UCB Biopharma, Almirall S.A., McCann Health) and from living abroad in the UK, Spain and Belgium. Paula is originally from Portugal and in the last six years she is living in Belgium with her family.

Pharma Launch Excellence Summit Main Conference Day 1: Tuesday 3rd December

10:00 AM Presentation/Case Study: Enhancing Launch Excellence: Strategic Role of Market Access in Sustained Performance and Progress

Delve into the importance to anticipate what changes mean for todays’ industry transformation in terms of sustainability, affordability of healthcare as well as equity of access across the globe

• Strategizing requires ability to be ambidextrous focusing on short-term without losing eyesight from long-term success and competitiveness.

• Developing a deeper focus on strategy is essential amongst disruptions from regulation (EU pharma regulation, IRA), digital transformation, and a quest to redefine innovation.

• Investing in patient-centric insights and targeted data generation is critical to ensure that breakthroughs translate into differentiated value propositions and optimised willingness to pay and to use.

Pharma Launch Excellence Summit Main Conference Day 2: Wednesday 4th December

Check out the incredible speaker line-up to see who will be joining Paula.

Download The Latest Agenda